TY - JOUR A1 - Kurz, Alexander A1 - Rabbani, Naila A1 - Walter, Michael A1 - Bonin, Michael A1 - Thornalley, Paul A1 - Auburger, Georg A1 - Gispert, Suzana T1 - Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress T2 - Cellular and molecular life sciences N2 - The presynaptic protein alpha-synuclein has received much attention because its gain-of-function is associated with Parkinson’s disease. However, its physiological function is still poorly understood. We studied brain regions of knock-out mice at different ages with regard to consistent upregulations of the transcriptome and focused on glyoxalase I (GLO1). The microarray data were confirmed in qPCR, immunoblot, enzyme activity, and behavior analyses. GLO1 induction is a known protective cellular response to glucose stress, representing efforts to decrease toxic levels of methylglyoxal (MG), glyoxal and advanced glycation endproducts (AGEs). Mass spectrometry quantification demonstrated a ubiquitous increase in MG and fructosyl-lysine as consequences of glucose toxicity, and consistent enhancement of certain AGEs. Thus, GLO1 induction in KO brain seems insufficient to prevent AGE formation. In conclusion, the data demonstrate GLO1 expression and glycation damage to be induced by alpha-synuclein ablation. We propose that wild-type alpha-synuclein modulates brain glucose metabolism. KW - Alpha-synuclein deficiency KW - Transcriptome microarray KW - Glyoxalase I KW - Advanced glycation endproducts KW - Glucose metabolism Y1 - 2010 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/33421 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-334218 SN - 1420-682X SN - 1420-9071 N1 - Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. VL - 68 IS - 4 SP - 721 EP - 733 PB - Springer CY - Basel ER -